Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 1-7

  Lawton, Colleen A ^a   Hunt, Daniel ^b   Lee, W Robert ^c   Gomella, Leonard ^d   Grignon, David ^e   Gillin, Michael ^f   Morton, Gerard ^g   Pisansky, Thomas M ^h   Sandler, Howard ⁱ  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b RTOG Statistical Center   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^h MAYO CLINIC   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Low dose rate; Prostate

Indexed keywords

ANTIGENS; DISEASES; ONCOLOGY; RADIOACTIVITY; RADIOTHERAPY; TOXICITY; ULTRASONICS;

BRACHYTHERAPY; EXTERNAL BEAM RADIOTHERAPY; LOW DOSE RATE; OVERALL SURVIVAL RATES; PLANNING TARGET VOLUMES; PROSTATE; PROSTATE SPECIFIC ANTIGEN; TRANSRECTAL ULTRASOUND;

UROLOGY;

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLADDER DISEASE; BLEEDING; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL EFFECTIVENESS; DYSPNEA; ENDOCRINE DISEASE; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HEADACHE; HUMAN; IMPOTENCE; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROTOXICITY; OTOTOXICITY; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; REPRODUCTIVE TOXICITY; REVIEW; SKIN TOXICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 79961128020     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.056     Document Type: Article

References (18)

1. C.A. Lawton, M. DeSilvio, and W.R. Lee Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05) Int J Radiat Oncol BiolPhys 67 2007 39 47 (Pubitemid 44959487)
2. S.J. Feigenberg, W.R. Lee, and M.L. DeSilvio Health-Related quality of life in men receiving prostate brachytherapy on RTOG 98-05 Int J Radiat Oncol Biol Phys 62 2005 956 964 (Pubitemid 40884404)
3. ICRU Report 58 Dose and Volume Specification for Reporting Interstitial Therapy 1997 International Commission on Radiation Units and Measurements Bethesda, MD
4. AAPM Report #51. Dosimetry of Interstitial Brachytherapy Sources Reprinted from Med Phys 22 1995 209 234
5. Cancer Therapy Evaluation Program (CTEP). Available at: http://ctep.info.nih.gov/protocolDevelopment/electronic-applications/ctc. htm#ctc-20. Accessed February 26, 2010.
6. J.D. Cox, J. Stetz, and T.F. Pajack Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment for Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
7. G. Dhom, and S. Degro Therapy of prostatic cancer and histopathologic follow-up Prostate 3 1982 531 542 (Pubitemid 13176816)
8. M. Roach, G. Hanks, and H. Thames Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
9. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: Guidelines for PSA following radiotherapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
10. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
11. J.D. Kalbfleish, and R.L. Prentice The statistical analysis of failure time data 1980 John Wiley & Sons New York 167-169
12. L. Potters, C. Morgenstein, and E. Calugaru 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 173 2005 1562 1566 (Pubitemid 40524771)
13. M. Zelefsky, D. Kuban, and L. Levy Multi-institutional analysis of long-term outcome for states T1-T2 prostate cancer treated with permanent seed implantation Int Jf Radiat Oncol Biol Phys 67 2007 327 333 (Pubitemid 46108308)
14. A. Bill-Axelson, L. Holmberg, and F. Filen Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian Prostate Cancer Group-4 randomized trial J Natl Cancer Inst 100 2008 1144 1154
15. A. Stephenson, M. Kattan, and J. Easthan Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era J Clin Oncol 2009 27 2009 4300 4305
16. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy ≥ 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33 (Pubitemid 38010333)
17. R.G. Stock, N.N. Stone, and Y.C. Lo Post implant dosimetry for 125 iodine prostate implants. Definitions and factors affecting outcome Int J Radiat Oncol Biol Phys 48 2000 899 906
18. R.G. Stock, N.N. Stone, and A. Tabert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108 (Pubitemid 28211308)